In January, the US Food and Drug Administration (FDA) began the process of evaluating 199 studies of anti-seizure drugs commonly prescribed for epilepsy and other disorders due to reports of suicidal behaviors in patients taking them.  Their findings led them…

The US Food and Drug Administration (FDA) has announced plans to ask that a black-box warning be required of epilepsy drug labels due to an apparent increase in suicidal thoughts and behaviors associated with some of these drugs. A black-box…

A first-of-kind study was presented to members of the American Academy of Neurology attending that group’s 60th Anniversary Annual Meeting, running from April 12 through 19, in Chicago.  The study measured negative cognitive impact of an infant when his or…